7
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Relationship Between Odor Intensity Estimates and COVID-19 Prevalence Prediction in a Swedish Population

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In response to the coronavirus disease 2019 (COVID-19) pandemic, countries have implemented various strategies to reduce and slow the spread of the disease in the general population. For countries that have implemented restrictions on its population in a stepwise manner, monitoring of COVID-19 prevalence is of importance to guide the decision on when to impose new, or when to abolish old, restrictions. We are here determining whether measures of odor intensity in a large sample can serve as one such measure. Online measures of how intense common household odors are perceived and symptoms of COVID-19 were collected from 2440 Swedes. Average odor intensity ratings were then compared to predicted COVID-19 population prevalence over time in the Swedish population and were found to closely track each other ( r = −0.83). Moreover, we found that there was a large difference in rated intensity between individuals with and without COVID-19 symptoms and the number of symptoms was related to odor intensity ratings. Finally, we found that individuals progressing from reporting no symptoms to subsequently reporting COVID-19 symptoms demonstrated a large drop in olfactory performance. These data suggest that measures of odor intensity, if obtained in a large and representative sample, can be used as an indicator of COVID-19 disease in the general population. Importantly, this simple measure could easily be implemented in countries without widespread access to COVID-19 testing or implemented as a fast early response before widespread testing can be facilitated.

          Related collections

          Most cited references19

          • Record: found
          • Abstract: found
          • Article: not found

          A Novel Coronavirus from Patients with Pneumonia in China, 2019

          Summary In December 2019, a cluster of patients with pneumonia of unknown cause was linked to a seafood wholesale market in Wuhan, China. A previously unknown betacoronavirus was discovered through the use of unbiased sequencing in samples from patients with pneumonia. Human airway epithelial cells were used to isolate a novel coronavirus, named 2019-nCoV, which formed a clade within the subgenus sarbecovirus, Orthocoronavirinae subfamily. Different from both MERS-CoV and SARS-CoV, 2019-nCoV is the seventh member of the family of coronaviruses that infect humans. Enhanced surveillance and further investigation are ongoing. (Funded by the National Key Research and Development Program of China and the National Major Project for Control and Prevention of Infectious Disease in China.)
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            A pneumonia outbreak associated with a new coronavirus of probable bat origin

            Since the outbreak of severe acute respiratory syndrome (SARS) 18 years ago, a large number of SARS-related coronaviruses (SARSr-CoVs) have been discovered in their natural reservoir host, bats 1–4 . Previous studies have shown that some bat SARSr-CoVs have the potential to infect humans 5–7 . Here we report the identification and characterization of a new coronavirus (2019-nCoV), which caused an epidemic of acute respiratory syndrome in humans in Wuhan, China. The epidemic, which started on 12 December 2019, had caused 2,794 laboratory-confirmed infections including 80 deaths by 26 January 2020. Full-length genome sequences were obtained from five patients at an early stage of the outbreak. The sequences are almost identical and share 79.6% sequence identity to SARS-CoV. Furthermore, we show that 2019-nCoV is 96% identical at the whole-genome level to a bat coronavirus. Pairwise protein sequence analysis of seven conserved non-structural proteins domains show that this virus belongs to the species of SARSr-CoV. In addition, 2019-nCoV virus isolated from the bronchoalveolar lavage fluid of a critically ill patient could be neutralized by sera from several patients. Notably, we confirmed that 2019-nCoV uses the same cell entry receptor—angiotensin converting enzyme II (ACE2)—as SARS-CoV.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

              Summary The recent emergence of the novel, pathogenic SARS-coronavirus 2 (SARS-CoV-2) in China and its rapid national and international spread pose a global health emergency. Cell entry of coronaviruses depends on binding of the viral spike (S) proteins to cellular receptors and on S protein priming by host cell proteases. Unravelling which cellular factors are used by SARS-CoV-2 for entry might provide insights into viral transmission and reveal therapeutic targets. Here, we demonstrate that SARS-CoV-2 uses the SARS-CoV receptor ACE2 for entry and the serine protease TMPRSS2 for S protein priming. A TMPRSS2 inhibitor approved for clinical use blocked entry and might constitute a treatment option. Finally, we show that the sera from convalescent SARS patients cross-neutralized SARS-2-S-driven entry. Our results reveal important commonalities between SARS-CoV-2 and SARS-CoV infection and identify a potential target for antiviral intervention.
                Bookmark

                Author and article information

                Journal
                Chem Senses
                Chem. Senses
                chemse
                Chemical Senses
                Oxford University Press (UK )
                0379-864X
                1464-3553
                22 May 2020
                : bjaa034
                Affiliations
                [1 ] Department of Clinical Neuroscience, Karolinska Institutet , Stockholm, Sweden
                [2 ] Department of Psychology, Stockholm University , Stockholm, Sweden
                [3 ] Department of Neurobiology, Weizmann Institute of Science , Rehovot, Israel
                [4 ] Department of Otolaryngology—Head and Neck Surgery, Edith Wolfson Medical Center , Holon, Israel
                [5 ] Vestre Viken, Kongsberg Hospital and Psychological Institute, University in Oslo , Forskningsveien, Oslo, Norway
                [6 ] Department of Applied Biological Chemistry, Graduate School of Agricultural and Life Sciences, The University of Tokyo , Yayoi, Bunkyo-ku, Tokyo, Japan
                [7 ] Champalimaud Research, Champalimaud Centre for the Unknown , Av. Brasília, Lisbon, Portugal
                [8 ] Department of Agriculture, Food, Environment and Forestry, University of Florence , Florence, Italy
                [9 ] Rhinology and Skull Base Surgery Unit, Otorhinolaryngology Department, Ramón y Cajal University Hospital , Madrid, Spain
                [10 ] Lyon Neuroscience Research Center, CNRS—INSERM—University Claude Bernard of Lyon , Bron, France
                [11 ] Faculty of Social and Behavioral Sciences, Utrecht University , Heidelberglaan, CS Utrecht, the Netherlands
                [12 ] Smell and Taste Clinic, Department of Otorhinolaryngology, TU Dresden , Fetscherstrasse, Dresden, Germany
                [13 ] Monell Chemical Senses Center , Philadelphia, PA, USA
                Author notes
                Correspondence to be sent to Johan N. Lundström, Department of Clinical Neuroscience, Karolinska Institutet, Nobels väg 9, 17177 Stockholm, Sweden. e-mail: johan.lundstrom@ 123456ki.se

                These authors contributed equally to the work.

                Author information
                http://orcid.org/0000-0001-9905-1067
                http://orcid.org/0000-0002-2991-3036
                http://orcid.org/0000-0001-9713-0183
                http://orcid.org/0000-0002-3529-8981
                Article
                bjaa034
                10.1093/chemse/bjaa034
                7314115
                32441744
                97831bc7-6a5f-4188-b30c-639cb0cfada5
                © The Author(s) 2020. Published by Oxford University Press.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 19 May 2020
                : 06 June 2020
                Page count
                Pages: 8
                Funding
                Funded by: European Research Council, DOI 10.13039/100010663;
                Award ID: 670798
                Funded by: Knut och Alice Wallenbergs Stiftelse, DOI 10.13039/501100004063;
                Award ID: 2018.0152
                Categories
                Original Article
                AcademicSubjects/SCI01180
                Custom metadata
                PAP
                corrected-proof

                Molecular biology
                anosmia,coronavirus,covid-19,olfactory dysfunction,population prevalence
                Molecular biology
                anosmia, coronavirus, covid-19, olfactory dysfunction, population prevalence

                Comments

                Comment on this article